+ 1.24
+ 0.41%
+ 2.49
+ 0.83%
+ 3.11
+ 0.85%

MediPharm Labs Brings A Pharmaceutical Approach To Cannabis

August 18, 2020 10:47 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Don’t miss this opportunity to connect with THE cannabis movers and shakers from across the globe during Benzinga’s Virtual Cannabis Capital Conference on August 18. Among the attendees is MediPharm Labs.
Integrity, innovation and collaboration are the three core values of this cannabis company.
Serving the global medical and wellness markets, MediPharm Labs manufactures pure, trusted and precisely dosed cannabis concentrates for advanced derivative products.
President and Co-Founder of MediPharm Labs Keith Strachan will be speaking at the upcoming Virtual Cannabis Capital Conference to update the industry and market on the company’s latest work and opportunities which are focused on driving growth.

The MediPharm Approach 

One factor that differentiates MediPharm Labs’ cannabis position in the industry is its pharmaceutical approach to cannabis and its global Good Manufacturing Practices (GMP) Certified platform, with locations in Canada and Australia. This approach has positioned the company to win in new emerging jurisdictions legalizing medical cannabis by providing its customers access to its global supply chain and finished product contract manufacturing while meeting the needs of future large pharma and CPG companies entering cannabis.
“We are encouraged with the pace of growth of new and emerging international cannabis markets as well as the global GMP platform MediPharm has invested in to become the go-to provider for large pharmaceutical and CPG companies entering cannabis space with exciting new products for consumers and medical patients around the world,” said Strachan.
MediPharm Labs’ two GMP certified facilities and extensive extraction process which uses Supercritical CO2 extraction for its primary extraction are outlined on their website along with their distillation, purification and end-product manufacturing methods.
To learn more about MediPharm Labs, you can sign up for the Benzinga Virtual Cannabis Capital Conference by clicking here.

Photo by Rick Proctor on Unsplash

Related Articles

Sweet Dirt Expands In Maine, Opens Adult-Use Cannabis Store In Waterville

Cannabis company Sweet Dirt is poised to launch the first out of four adult use cannabis retail locations in Central and Southern Maine. The new store — located at 475 Kennedy Memorial Drive in Waterville, Maine — will open on Wednesday, Dec. 9. The ribbon-cutting ceremony is scheduled for Monday, Dec. 7. read more

No One Size Fits All: Cannabis Experts Discuss Merits Of Capped, Uncapped Markets

Cannabis regulations vary by state, with license caps serving as one of the more glaring differences. Depending where you are, caps may or may not be imposed on various points in the supply chain, which can include limits on ownership, production, delivery or retail. read more

MedC Biopharma Corporation Launches $3M Private Placement Offering

Skin oncology medication manufacturer MedC Biopharma Corp. is launching its $3 million private placement offering. The company known for various products with cannabinoid and other natural ingredients launched the private placement via the DealSquare platform, which is supported by NEO and DealMaker technology. read more

Aleafia Health Presents Debuts High Potency CBD 50 Cannabis Oil

Aleafia Health Inc. (TSX: AH) (OTCQX: ALEAF) is launching high potency CBD 50 oils. The cannabis company crafted SymblTM High CBD 50 and EmblemTM CBD 50 to meet the needs of both adult-use consumers and medical patients, respectively. read more

Merry Marijuana: 8 Ganja Gift Ideas For Loved Ones Who Wish To Enjoy A Holiday High

It may not feel like it this year, but yes — the holidays are upon us. Indeed, shopping for gifts will be different since the coronavirus pandemic will likely keep many of us from going to stores.  read more